Atrial fibrillation in the young: clinical characteristics, predictors of new onset and outcomes

Back

EHRA Premium Access

Atrial fibrillation in the young: clinical characteristics, predictors of new onset and outcomes

Session: How do we translate the '2020 ESC Guidelines on Atrial Fibrillation' into clinical practice?

Topic: Treatment

Speaker: Doctor A. Segev (Ramat Gan, IL)

Event: EHRA 2021

Congress Presentation

About the speaker

Doctor Amitai Segev

Sheba Medical Center, Ramat Gan (Israel)

2 presentations

0 follower

4 more presentations in this session

The 4 S score: how and when do I use it?

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Access

Slides

Video

The atrial fibrillation better-care pathway: indications for ablation

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Access

Slides

Video

Risk factor management before ablation

Speaker: Professor M. Rienstra (Groningen, NL)

Access

Slides

Video

How do we translate the '2020 ESC Guidelines on Atrial Fibrillation' into clinical practice? - discussion

Access

Access the full session

How do we translate the '2020 ESC Guidelines on Atrial Fibrillation' into clinical practice?

Speakers: Doctor A. Segev, Associate Professor T. Potpara, Professor C. Blomstrom-Lundqvist, Professor M. Rienstra

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

Atrial fibrillation in the young: clinical characteristics, predictors of new onset and outcomes

About the speaker

Doctor Amitai Segev

4 more presentations in this session

The 4 S score: how and when do I use it?

The atrial fibrillation better-care pathway: indications for ablation

Risk factor management before ablation

How do we translate the '2020 ESC Guidelines on Atrial Fibrillation' into clinical practice? - discussion

Access the full session

How do we translate the '2020 ESC Guidelines on Atrial Fibrillation' into clinical practice?

About the event

EHRA 2021

ESC 365 is supported by